文献速递临床试验与 GCP

重度慢性阻塞性肺疾病患者的多维度个体化营养治疗:基于注册的随机对照试验研究方案

Multidimensional individualized nutritional therapy for individuals with severe chronic obstructive pulmonary disease: study protocol for a registry-based randomized controlled trial.
PubMed 文献 · Trials · 2023-02-06

本方案为在丹麦哥本哈根大学医院北新西兰分院肺科门诊招募重度慢性阻塞性肺疾病(COPD)患者的开放标签、两组平行随机对照试验,干预组接受为期3个月的个体化营养干预联合标准治疗,对照组仅接受标准治疗。主要结局为基线后3个月两组间健康相关生活质量(EQ-5D-5L)的差异,并设功能能力、疾病特异性生活质量、焦虑抑郁、营养参数、人体测量、身体成分及预后等次要结局。

要点

  • 干预为期3个月,含个体化营养计划、定期联系、依从性支持与体重日记4个要素。
  • 主要结局为基线后3个月两组间EQ-5D-5L健康相关生活质量的差异。
  • 数据通过基线、基线后1个月和3个月的家庭访视收集。

核心结论

  • 作者认为,若这一以患者为中心的方法能对健康相关生活质量、死亡率和医院接触显示积极影响,应将其作为重度COPD患者临终关怀的一部分予以推荐。

研究设计与样本

  • 开放标签随机对照试验,两组平行设计;从丹麦哥本哈根大学医院北新西兰分院肺与感染性疾病科肺科门诊招募重度COPD患者,随机分配至干预组(干预+标准治疗)或对照组(标准治疗)。

主要发现

  • 主要结局为基线后3个月干预组与对照组之间健康相关生活质量(EQ-5D-5L)的差异。
  • 次要结局包括基线后3个月的功能能力(握力、30秒坐立试验和体力活动)、疾病特异性生活质量(COPD评估测试)、焦虑与抑郁(医院焦虑抑郁量表)、营养参数(能量与蛋白质摄入)、人体测量(体重、体质指数、腰围、臀围和上臂围)、身体成分(总去脂体重与脂肪质量及指数)和预后(急性加重、氧疗、医院接触和死亡率)。
  • 数据通过基线、基线后1个月和3个月的家庭访视收集。

临床怎么用

  • 作者认为,若该以患者为中心的方法能对健康相关生活质量、死亡率和医院接触显示积极影响,应作为重度COPD患者临终关怀的一部分予以推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Individuals with severe chronic obstructive pulmonary disease (COPD) are often at risk of undernutrition with low health-related quality of life (HRQoL). Undernutrition can worsen COPD and other comorbidities, be an independent predictor of morbidity and functional decline resulting in increased healthcare consumption and increased risk of death. Especially exacerbations and acute infections result in unintentional weight loss. The aim is to investigate the effect of an individualized nutritional intervention among individuals with severe COPD. METHODS: An open-label randomized controlled trial with two parallel groups. Participants are recruited from the pulmonary outpatient clinic at the Department of Pulmonary and Infectious Diseases, Copenhagen University Hospital, North Zealand, Denmark, and randomly allocated to either the intervention (intervention + standard of care) or control group (standard of care). The intervention has a duration of 3 months and combines individual nutritional care with adherence support and practical tools. It contains 4 elements including an individual nutritional plan, regular contacts, adherence support, and weight diary. The primary outcome is a difference in HRQoL (EQ-5D-5L) between the intervention and control group 3 months after baseline. Difference in functional capacity (grip strength, 30-s stand chair test, and physical activity), disease-specific quality of life (COPD Assessment Test), anxiety and depression (Hospital Anxiety and Depression Scale), nutritional parameters (energy and protein intake), anthropometry (weight, body mass index, waist, hip, and upper arm circumference), body composition (total fat-free and fat mass and indices), and prognosis (exacerbations, oxygen therapy, hospital contacts, and mortality) 3 months after baseline will be included as secondary outcomes. Data will be collected through home visits at baseline and 1 and 3 months after baseline. DISCUSSION: Currently, nutritional care is a neglected area of outpatient care among individuals with severe COPD. If this patient-centered approach can demonstrate a positive impact on HRQoL, mortality, and hospital contacts, it should be recommended as part of end-of-life care for individuals with severe COPD. TRIAL REGISTRATION: ClinicalTrials.gov NCT04873856 . Registered on May 3, 2021.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Hegelund MH, Ritz C, Nielsen TL, et al. Multidimensional individualized nutritional therapy for individuals with severe chronic obstructive pulmonary disease: study protocol for a registry-based randomized controlled trial. Trials. 2023. PMID: 36747276. doi:10.1186/s13063-023-07099-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。